|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Short-term marketable securities | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Long term marketable securities | |||||||||||||
| Operating lease right-of-use assets | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and stockholders' equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Operating lease liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Operating lease liabilities, long-term | |||||||||||||
| Warrant liability | |||||||||||||
| Liabilities, Total | |||||||||||||
| Stockholders' equity: | |||||||||||||
| Undesignated preferred stock, $0.0001 per share: 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||||||||||
| Common stock | |||||||||||||
| Series A Common Stock | |||||||||||||
| Series B Common Stock | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||
Loading...